This topic contains a solution. Click here to go to the answer

Author Question: A problem with cross-sectional research is that cohort differences can make it difficult to ... (Read 162 times)

joblessjake

  • Hero Member
  • *****
  • Posts: 555
A problem with cross-sectional research is that
 
  cohort differences can make it difficult to differentiate between developmental
  change and cohort differences.
  retesting leads older subjects to do better.
  the most intelligent people are most likely to drop out of the study.
  the results tend not to be worth the large investment.

Question 2

Research that analyzes the cognitive development of the same individuals as they develop over the years is called:
 
  cross-sectional research.
  representative samples.
  longitudinal research.
  sequential research.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Fayaz00962

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

cohort differences can make it difficult to differentiate between developmental
change and cohort differences.

Answer to Question 2

longitudinal research.





 

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library